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Abstract: The economics of managing disease transmission at the wildlife–livestock interface 
have received heightened attention as agricultural and natural resource agencies struggle 
to tackle growing risks to animal health. In the ? scal landscape of increased scrutiny and 
shrinking budgets, resource managers seek to maximize the bene? ts and minimize the costs 
of disease mitigation efforts. To address this issue, a bene? t-cost analysis decision framework 
was developed to help users make informed choices about whether and how to target disease 
management efforts in wildlife and livestock populations. Within the context of this framework, 
we examined the conclusions of a bene? t-cost analysis conducted for vampire bat (Desmodus 
rotundus) rabies control in Mexico. The bene? t-cost analysis decision framework provides 
a method that can be used to identify, assemble, and measure the components vital to the 
biological and economic ef? ciencies of animal disease mitigation efforts. The framework can 
be applied to commercially-raised and free-ranging species at various levels of management 
– from detailed intervention strategies to broad programmatic actions. The ability of bene? t-
cost analysis to illustrate the bene? ts of disease management projects per dollar spent allows 
for the determination of economic ef? ciency of alternative management actions. We believe 
this framework will be useful to the broader natural resource management community to 
maximize returns on ? nancial and other resources invested in wildlife and livestock disease 
management programs.
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A natural outcome of human population 
growth has been the juxtaposition of human 
activities and enterprises with natural features 
of the environment, including wildlife habitat. 
Expanding zones of contact between animal 
agriculture (e.g., livestock, captive wildlife, and 
companion animals) and free-ranging wildlife 
have arguably led to increasing risks to animal 
health, both for domestic livestock and for 
wildlife populations (Rhyan and Spraker 2010, 
Miller et al. 2013).
Disease transmission at the wildlife–livestock 
interface has the ability to signi? cantly impact 
human health, threaten global trade and 
tourism, cause signi? cant economic loss, and 
provide a potential mechanism for bio-terrorism. 
Evidence of these impacts can be seen through 
the examples of brucellosis, tuberculosis, avian 
in? uenza virus H5N1, foot-and-mouth disease 
(FMD), severe acute respiratory syndrome, 
human African trypanosomiasis, rabies, and 
anthrax. 
Outbreaks of avian in? uenza virus H5N1 
in Africa, Asia, and Europe resulted in an 
estimated loss to the poultry industry of $10 
billion in 2005, as well as the destruction or loss 
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of >200 million birds worldwide (FAO-OIE 2005, 
2007). Epizootics of FMD in Taiwan and Great 
Britain illustrate the potentially devastating 
economic impacts of infectious disease transfer 
to livestock markets. In 1997, the number of 
FMD positive cases in Taiwan reached 1 million 
swine and >3.85 million animals were destroyed 
(Yang et al. 1998). The highly contagious nature 
of FMD led to an export ban on pork from 
Taiwan in March of 1997. Prior to the outbreak, 
the country exported >$1.6 billion annually, 
accounting for 15% of global pork exports. 
Over a decade a? er the outbreak, Taiwan had 
not regained its high level of exports and had 
much lower hog populations, while the United 
States, Canada, and Denmark increased their 
pork export market share as a result (Blayney 
et al. 2006). A 2001 outbreak of FMD in Great 
Britain resulted in estimated losses of £3.1 
billion to the agriculture and food production 
sectors with additional tourism losses at least 
as great. It has been estimated that if FMD were 
to enter the United States, the economic losses 
would range from $12 billion to $228 billion 
with >30% of domestic livestock destroyed 
depending on the size and level of containment 
of the outbreak (Paarlberg et al. 2002, Boisvert 
et al. 2012, Oladosu et al. 2013). 
In the United States, 79% of the livestock 
diseases that are reportable to the World 
Organisation for Animal Health have a wildlife 
component associated with their transmission, 
maintenance, or life cycle (Miller et al. 2013). 
The pathway to economic impact of disease 
transmission at the wildlife–livestock interface, 
herea? er referenced as “the interface,” is usually 
from wildlife to livestock. But, the opposite 
case can become economically important 
when it helps maintain the disease reservoir 
in wildlife. A convergence of factors including 
land use changes, increasing frequency of 
contact between livestock and free-ranging 
wildlife, climate change, and the growth and 
intensi? cation of livestock production have 
increased the need for a systematic process to 
understand the economics of controlling disease 
transmission at the interface (Jones et al. 2013). 
The monetary burden of disease transmission 
at the interface can be broadly divided into 
the impacts to livestock production, impacts 
to human and wildlife health, changes to 
consumption demand, and costs associated 
with disease management or mitigation. 
The interfaces between wildlife, domestic 
animals, and humans provide many avenues to 
create economic losses resulting from disease 
transmission. O? en, the most direct or immediate 
impact of wildlife disease transmission is the 
e? ect on livestock populations (Cleaveland et 
al. 2001, Tschopp et al. 2010, IFAH 2012, Narrod 
et al. 2012). Livestock morbidity and mortality 
cause direct losses within the livestock sector, 
and these losses in turn negatively impact 
economic sectors that are linked to livestock 
production. Additionally, consumer spending 
and tax revenue may be a? ected as prices and 
spending pa? erns change.
Human health impacts from zoonotic disease 
transmission can result from infectious contacts 
with wildlife or livestock, both of which may 
also exchange pathogens with one another prior 
to spillover into humans (Jones et al. 2013). 
Regardless of the pathway, the human health 
burden from zoonotic disease transmission 
has been well documented and includes 
death, illness, and disability (Cleaveland et 
al. 2001, Jones et al. 2013). Estimates of costs 
associated with these e? ects are available in 
the literature and can have broader economic 
implications as a? ected individuals, businesses, 
and governments reallocate resources to pay 
for treatment costs.
 Consumers o? en react very quickly to real 
or perceived threats to human health and food 
safety and may avoid certain food products 
or tourist areas that are perceived as risky. 
These behaviors can be devastating to the 
economy. For example, in 2009, as pandemic 
H1N1 in? uenza spread into the United States, 
domestic pork consumption fell and exports 
from the United States decreased. Additionally, 
Russia and China, which represented almost 
30% of the U.S. pork export market prior to 
the 2009 outbreak, banned the importation 
of certain types of pork products from the 
United States. As a result of reduced domestic 
pork consumption and declining pork prices, 
the U.S. pork industry lost an estimated $270 
million in income in the second quarter of 2009 
(Johnson 2009).
The main purpose of disease management at 
the interface is to reduce or eliminate the risk of 
disease transmission from wildlife to livestock. 
Success can be measured as the damage (i.e., 
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losses, costs, etc.) avoided or in terms of the 
number of protected individuals, including 
humans, livestock, wildlife, and companion 
animals (Kapos et al. 2008). Management 
strategies are diverse and focus primarily 
on livestock populations (e.g., biosecurity 
measures, vaccination, husbandry practices). 
However, a few examples exist of disease 
management in wildlife populations. These 
include bovine tuberculosis (bTB, caused 
by Mycobacterium bovis), bovine brucellosis 
(caused by Brucella abortus), and rabies (caused 
by Lyssavirus spp.). 
Individual producer estimates of the bene? ts 
and costs of management strategies are crucial 
to disease control e? orts to gain producer 
involvement in mitigation e? orts. Individual 
producer resources are limited, and investment 
in disease management will depend on the 
size of the operation, available resources, 
intended market of the ? nished product, 
education level of the producer, and production 
technology (Hennessy 2005, 2007; Beach et al. 
2007). However, within any private market, 
producers will choose to invest in a particular 
management strategy up to the point where 
the expected private marginal bene? ts equal 
the expected private marginal costs (Beach et 
al. 2007). By their very nature, private markets 
provide neither an incentive nor a mechanism 
by which producers would consider the 
greater social costs or bene? ts of their disease 
management actions. As a result, one would 
expect private producers to under-invest 
in management from a social point of view 
(McCarthy et al. 2003). Because the broader 
society would prefer greater investment in 
disease management, this outcome is referred 
to as a “market failure.” 
Unlike individual producers, governments 
are expected to consider the total bene? ts and 
costs of disease transmission and mitigation. 
Disease management programs initiated by 
governments seek to achieve the optimal level 
of disease control by factoring in a broader set 
of components, including the impacts to overall 
disease containment in a region, impacts to 
wildlife and human health, and market impacts 
to consumers and the macroeconomy (Beach et 
al. 2007). Regardless of who initiates disease 
management at the interface, the economically 
e?  cient implementation of management e? orts 
requires a comprehensive understanding of 
savings derived from a reduction in disease 
transmission. 
In this paper, we provide a decision 
framework for bene? t-cost analyses of disease 
transmission mitigation at the wildlife–
livestock interface. Our methodology considers 
the potential impacts of disease mitigation 
to public health, animal health, and the 
economic sectors of a particular region. We 
illustrate the use of this framework by applying 
it to a previously conducted bene? t-cost 
analysis, which evaluated a variety of disease 
transmission management options for a speci? c 
disease.
Methods
Development of a bene? t-cost analysis 
decision framework for disease 
management
A general decision framework was 
developed for conducting bene? t-cost analyses 
of management actions designed to reduce the 
risk of disease transmission at the wildlife–
livestock interface (Figure 1). This framework 
is designed to measure and compare the value 
of management actions in terms of the direct 
bene? ts to impacted sectors (livestock, wildlife, 
humans, and their companion animals) and 
costs resulting from the management actions 
chosen to mitigate disease transmission in 
wildlife and livestock populations. When 
a? empting to reduce disease transmission at 
the interface, wildlife and livestock managers 
are faced with a suite of management options. 
Livestock-focused management options 
include con? nement of livestock or exclusion 
of wildlife through fencing or other means, 
improving biosecurity of farms, culling, 
livestock vaccination/treatment, and other 
husbandry practices (e.g., separation of sick 
animals) to manage disease. Wildlife-focused 
management options include population 
reduction, wildlife vaccination, and hazing of 
wildlife from livestock use areas. All disease 
management strategies have costs. The goal 
of these strategies is to reduce the probability 
of disease transmission at the interface, so the 
costs may be partially or completely o? set by 
the value of reduced damage. 
To measure economic e?  ciency, the 
framework allows for the quantitative 
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or qualitative comparison of alternative 
management strategies resulting in reduced 
disease transmission between wildlife and 
livestock populations. Bene? t-cost analysis 
is a commonly used tool to evaluate program 
activities by identifying and comparing the 
bene? ts and costs of alternative management 
e? orts (Nas 1996). Another metric, cost-
e? ectiveness analysis, may be used when 
bene? ts of alternate management programs are 
similar but di?  cult or impossible to monetize 
(Boardman et al. 1996). For example, cost-
e? ectiveness analysis would be appropriate for 
a disease management project that captures the 
costs and number of animals saved associated 
with each management e? ort but is unable to 
make any animal valuation estimates. Economic 
e?  ciency is achieved through the management 
approach that produces the greatest net 
present value of the bene? ts (Cullen et al. 2001; 
Engeman et al. 2002, 2003; Cullen et al. 2005; 
Caudell et al. 2010; Laycock et al. 2011).
Determining management costs. Costs (Ci), 
driven by management actions (i = 1, . . . , n), 
are o? en more straightforward to quantify 
than bene? ts (Shwi?  et al. 2013a). The general 
category of management costs associated with 
wildlife disease transmission mitigation can 
be broken down into operational (Ops) and 
spillover (Spill) costs (Figure 1), represented by:
Operational costs represent the ? nancial 
costs of project implementation and typically 
involve land purchase/lease, land management, 
equipment, labor, supplies, planning, 
negotiating, and other costs crucial to project 
completion and management. These costs 
can be obtained by keeping ? nancial records 
of all aspects of expenditures related to the 
project for a post-project assessment of costs. 
Spillover costs are burdens external to a project 
and can include costs that arise from reduced 
agricultural production, lost recreational 
opportunities, loss of competing species or 
habitat, increased human con? icts, and other 
Figure 1. Decision-making framework for bene? t-cost analysis of disease management options at the 
wildlife–livestock interface. Bene? ts (damages avoided) consist of consumption demand losses avoided 
(DAK), human health losses avoided (DAH), livestock losses avoided (DAL), and wildlife losses avoided (DAW).
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forgone uses of impacted wildlife species 
(Naidoo et al. 2006).
Assigning bene? t values. Estimating the total 
bene? ts of preventing or reducing disease 
spread from wildlife to livestock requires 
quanti? cation of market and non-market goods 
and services. An accepted methodology for 
determining these values is the damage avoided 
method, which uses the value of resources 
saved as a measure of bene? ts provided by the 
disease management program. In the current 
context, loss avoided is a function of 2 things: 1) 
impacts of a disease on livestock and/or wildlife 
in the absence of any management intervention, 
and 2) how e? ectively a particular management 
option in either wildlife or livestock reduces 
the probability (?) of disease impacts. Disease 
impacts may be estimated using stochastic 
simulation models or deterministic models, 
either in advance of an outbreak or a? er the 
outbreak occurs. Discussion of the factors 
that play a role in disease impacts are outside 
the scope of this manuscript, but include 
a? ected livestock and wildlife species, 
disease prevalence and susceptibility of host 
populations, contact rates between potential 
hosts, pathogen virulence and transmissibility, 
severity of clinical infection, presence of 
reservoir and carrier species, zoonotic potential, 
and the e? ectiveness of particular management 
options. The general framework presented 
in Figure 1 allows users to insert underlying 
equations and assumptions to parameterize the 
framework’s variables.
Damage avoided (bene? ts) consist of 4 
general components: consumption demand 
losses avoided (DAK), human health losses 
avoided (DAH), livestock losses avoided (DAL), 
and wildlife losses avoided (DAW), and their 
monetary valuations, ?. This relationship is 
represented by the following equation, where 
i = 1, . . . , n represents the management actions 
being evaluated.
For example, if 2 management options are 
being considered—1 in wildlife populations 
(e.g., vaccination) and 1 in livestock populations 
(e.g., fencing)—then ?W V would represent the 
bene? ts derived from the 4 components (DAK, 
DAH, DAL, DAW) through vaccination of 
wildlife populations, while ?LF would measure 
the bene? ts derived from fencing around 
livestock facilities.
Damage avoided valuation (?) is dependent 
upon the component being valued. Valuation 
of consumption demand losses avoided (?K) 
is a function of reduced consumption demand 
(domestic and international) for livestock 
products due to real or perceived threats to 
human health or food safety. This variable 
represents a reduction in quantity demanded 
(a shi?  in the demand curve) for the a? ected 
commodity and can be quanti? ed by a change 
in consumer surplus with special care taken 
to avoid any possible double counting. The 
ability of individual consumers to substitute 
away from certain livestock products, as well 
as consumer taste and preferences, in? uence 
the size of this variable. Export bans, supply 
constraints, and movement restrictions can 
a? ect consumer ability to purchase the livestock 
product.
Valuation of human health loss avoided 
(?H) is a function of disease morbidity and 
mortality in humans and direct and indirect 
costs of disease management. We include 
companion animals in this variable. Therefore, 
if the disease is not zoonotic, this variable will 
re? ect only companion animal costs. Direct 
costs include medical treatment expenses and 
reduced quantity and quality of human health 
(Jones et al. 2013). Many established methods 
exist to value direct losses to human health 
including quality-adjusted-life years (QALY), 
disability-adjusted-life years (DALY), or value-
of-statistical life (VSL; Shwi?  et al. 2013b). Both 
QALY and DALY measurements are expressly 
designed to estimate the impacts to human 
health as a result of disease burden. VSL 
provides a measure of the marginal value of a 
change in human mortality risk. Indirect costs 
include lost work time and companion animal 
impacts (Shwi?  et al. 2007).
In terms of disease transfer at the interface, 
livestock losses are commonly reported as the 
most signi? cant source of economic impact 
(IFAH 2012). Livestock mortality (?L) loss is 
based on the market value of the animal at time 
of death while morbidity loss can be calculated 
from the value of reduction in weight, decreased 
production, or increased veterinary costs.
Given that free-ranging wildlife typically do 
not have de? ned market values, valuation of 
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wildlife (?W) can occur through survey methods, 
such as the contingent valuation method and 
travel cost method (TCM), as well as non-
survey methods, such as bene? t-transfer. The 
contingent valuation method is a survey-based, 
stated preference approach to estimate use 
and existence values associated with wildlife 
species (Kotchen and Reiling 1998). This 
method solicits responses from individuals 
regarding their willingness to pay for increased 
wildlife populations. By varying the amount 
that respondents are asked to pay, a social value 
of the outcome is constructed (Loomis 1990). 
TCM is another survey approach, which uses 
costs incurred for travel to quantify demand 
for recreational activities linked to a species 
of interest (Kotchen and Reiling 1998). TCM is 
based on the idea that as some environmental 
amenity changes, the amount that people are 
willing to pay to use it will change, and that 
the change in willingness to pay is revealed by 
a change in travel costs. The bene? t-transfer 
method relies on bene? t values derived from 
the contingent valuation method and TCM 
studies in 1 area, which can be transferred 
to similar species at another location while 
adjusting the values for di? erences in incomes 
or prices between locations.
Bene? t-cost ratios. Combining the relevant 
information on bene? ts and costs allows the 
calculation of bene? t-cost ratios (BCRs). Net 
bene? ts can be calculated by subtracting the 
denominator from the numerator.  
BCR estimates of >1.0, or positive net bene? ts, 
indicate that the proposed management actions 
would be economically e?  cient. 
Application of the framework to 
vampire bat rabies in Mexico
Vampire bat rabies causes signi? cant impacts 
within its endemic range in Mexico. Animal testing 
costs, post-exposure prophylaxis costs, human 
mortality risk, and cattle losses comprise most of 
the economic costs associated with vampire bat-
transmitted rabies in Mexico (Arambulo and Thakur 
1992). Mitigation of the impacts can be achieved 
by 2 approaches: cattle vaccination and vampire 
bat population control. Anderson et al. (2012) 
conducted a bene? t-cost analysis to evaluate these 2 
mitigation strategies. We examined the methodology 
and conclusions of that analysis within the context 
of our framework.
Inclusion of speci? c bene? ts and costs depend 
on who is given standing, or whose perspective is 
being considered. In this case, private bene? ts and 
costs are those that accrue to livestock producers. 
A broader examination of the social bene? ts and 
costs considers not only impacts to producers, but 
also reductions in the use of human post-exposure 
prophylaxis and animal tests, which bene? t 
individuals not necessarily involved in livestock 
production. To account for uncertainty in the true 
value of these parameters, Anderson et al. (2012) 
conducted Monte Carlo simulations, estimating 
a range of parameter values. These variables 
were applied to our bene? t-cost analysis decision 
framework and are presented in Table 1, along with 
the analogous variables used in our framework. The 
bene? t-cost analysis framework applied to this data 
is presented in Figure 2.
Three vampire bat rabies management 
scenarios are considered in this study. In the 
? rst, the producer is given standing so only 
the costs from cattle pre-exposure vaccination 
and the bene? ts derived from that vaccination 
are factored into the decision making process. 
Producer management costs are operational and 
consist of the total quantities of vaccine, coolers, 
ice, and fuel multiplied by their prices (OpsL). 
Bene? ts are based on the cattle population (N) 
and the market price of cattle (?L) as well as the 
reduction in disease impacts (?L), which is a 
function of rabies-related cattle mortality (M) and 
vaccine effectiveness (V).
The bene? t-cost ratio (BCR) for the producer is 
determined by the following equation: 
From a social perspective, there are 2 publicly 
funded strategies available to mitigate vampire 
bat rabies disease impacts. First, vampire bat 
populations can be reduced to decrease the 
likelihood of vampire bat contact with humans 
and animals, consequently reducing the number 
of post-exposure prophylaxis and animal tests. 
Second, public funding could be used to control 
vampire bat populations as well as subsidize 
ca? le vaccination, which would reduce the 
number of post-exposure prophylaxis and 
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animal tests and would reduce ca? le mortality. 
The ? rst option is characterized by:  
The second option combines management 
of livestock and wildlife populations and 
is characterized by the following equation. 
Because livestock vaccination is subsidized 
in this scenario, the social bene? ts of reduced 
animal tests are included.
Results
Anderson et al. (2012) calculated bene? t-
cost ratios for 3 alternative vampire bat rabies 
mitigation programs: a private option in which 
livestock producers bear the cost of rabies 
mitigation and reap the bene? ts, and 2 social 
options in which costs and bene? ts extend 
beyond producers to the broader society. The 
? rst social option involved vampire bat control, 
and the second option added subsidized ca? le 
vaccination.
Under the private mitigation scenario, mean 
bene? t-cost ratios ranged from 6.42 to 6.64 for 
the producer, indicating that for every $1 the 
producer spent to vaccinate ca? le, >$6 in bene? ts 
were received. In other words, the return to 
producers in terms of reduced ca? le mortality 
was >6 times the investment in vaccination. 
Clearly, from the producer’s perspective, 
vaccinating ca? le to reduce livestock mortality 
is economically e?  cient.
Bene? t-cost ratios for the ? rst social 
management option, bat population reduction, 
ranged from 0.36 to 0.38. This result indicated 
economic ine?  ciency in that for every $1 spent 
on the program, <$1 was returned in bene? ts. 
In contrast, including all the bene? ts and costs 
accrued by managing vampire bat rabies in both 
Figure 2. Bene? t-cost analysis framework for vampire bat rabies management from producer and social 
perspectives. DAH indicates human health losses avoided; DAL indicates livestock losses avoided.
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wildlife and livestock populations returned 
mean BCRs that ranged from 6.32 to 6.52.
Using our framework to map out the 
pathways by which bene? ts are derived and 
costs incurred allows for the straightforward 
understanding of variables involved in the 
determination of economic e?  ciency. When 
only operational costs and bene? ts to livestock 
and/or human health are considered, the results 
clearly indicate that the economically e?  cient 
management of vampire bat rabies consisted 
of intervention on the livestock side of the 
interface. This was the case whether rabies 
management is undertaken by producers or in 
the public sector. Intervention on the wildlife 
side of the interface is economically ine?  cient. 
Insight is gained through the framework in 
that results can be framed in the context of 
omi? ed components, and policy makers can 
determine the validity of the results given their 
valuation of the relative importance of the 
omi? ed variables. In this analysis, the impacts 
to consumer demand as well as the overall 
impact of rabies to vampire bat populations 
are likely to be negligible; therefore, even with 
the inclusion of information regarding these 
variables, the results are expected to remain 
valid.
Anderson et al. variables Bene? t-cost analysis framework variables
Variable Description Variable Description
N Ca? le population N Ca? le population
M Ca? le mortality rate
?L
Decrease of ca? le disease impacts as a result 
of livestock vaccinationV Vaccine e? ectiveness
PEP % PEP avoided ?PEP
Decrease in disease impacts to humans as a 
result of bat control
AT % AT avoided ?AT
Decrease in disease impacts to humans as a 
result of vaccine subsidies
Pn Market price of ca? le ?L Market price of ca? le
Ppep Unit cost of PEP ?PEP Price of PEP
Pat Unit cost of animal tests ?AT Price of AT
Qpep Quantity of PEP QPEP Quantity of PEP
Qat Quantity of animal tests QAT Quantity of AT
Pv Unit cost of vaccine
OpsL Livestock vaccination program cost
Qv Quantity of vaccine
Pc Unit cost of coolers
Qc Quantity of coolers
Pi Unit cost of ice
Qi Quantity of ice
Pf Unit cost of fuel
Qf Quantity of fuel
B Bat control program cost OpsW Bat control program cost
T?b?? 1. Variables used by Anderson et al. (2012) with analogous bene? t-cost analysis framework 
variables.
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Discussion
This manuscript provides a systematic 
framework to evaluate objectively the economic 
e?  ciency of methods to mitigate disease 
transmission at the wildlife–livestock interface. 
This method allows for comparisons of multiple 
management strategies across regions, diseases, 
types of livestock, and wildlife species. The 
utility of this framework is its ? exibility; the 
general components that should be present in a 
bene? t-cost or other economic analysis of disease 
management strategies are provided. Users can 
insert underlying equations and assumptions 
to inform the framework’s variables. Modeling 
so? ware can be used to simulate factors such as 
probability of disease transmission, estimates of 
morbidity and mortality losses for a particular 
disease, susceptibility of livestock populations, 
probability of pathogen transmission, 
likelihood of clinical infection, and others.
Conversely, the framework can be simpli? ed 
in the absence of sophisticated parameter 
estimates. This approach can be used to 
provide more qualitative estimates of the 
components in the framework to obtain a 
less rigorous estimation of potential impacts 
and management costs. The level of rigor 
provided by the framework is a function of 
data availability. Additional ? exibility in the 
framework allows it to be adapted to other 
se? ings, for example, to examine impacts at 
the wildlife–human interface or the wildlife–
companion animal interface. This analysis 
focuses primarily on quantifying the impacts of 
disease transmission from wildlife to livestock; 
however, disease transmission from livestock 
to wildlife can also have costly implications. 
Livestock production in the United States 
is interconnected and concentrated. Disease 
threats to food safety or livestock health have 
the potential to quickly ripple through a region, 
pushing impacts beyond livestock producers 
to the entire U.S. economy. Additionally, real 
or perceived risks to human health including 
direct contact with diseased animals as well 
as consumption of contaminated meat, dairy, 
or poultry products may result in broader 
economic impacts, some of which may be long 
lasting.
Management implications
Tighter budgets and increased ? scal scrutiny 
have resulted in limited resources to mitigate 
disease threats in the United States, emphasizing 
the need to use these resources e?  ciently by 
employing management strategies that will 
provide the biggest return on investment. The 
bene? t-cost analysis framework described here 
can be used to identify, assemble, and measure 
the components critical to the economic 
e?  ciency of animal disease mitigation e? orts. 
In many cases, a lack of data, or inability to 
quantify bene? ts, may drive economic analyses 
toward a simpler method, such as cost-
e? ectiveness analysis. Given the importance 
and potential impacts of disease transmission at 
the wildlife–livestock interface, we created this 
methodology to aid in maximizing the return 
on resources invested in disease management 
programs.
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